A Non-Toxic Binuclear Vanadium(IV) Complex as Insulin Adjuvant Improves the Glycemic Control in Streptozotocin-Induced Diabetic Rats
Authors:
- Mateus S. LopesMLMateus S. Lopes
- Gabriel B. BaptistellaGabriel B. Baptistella
- Giovana G. NunesGNGiovana G. Nunes
- Matheus V. FerreiraMFMatheus V. Ferreira
- Joice Maria CunhaJCJoice Maria Cunha
- Kauê Marcel de OliveiraKOKauê Marcel de Oliveira
- Alexandra AccoAAAlexandra Acco
- Maria Luiza C. LopesMLMaria Luiza C. Lopes
- Alexessander Couto AlvesAlexessander Couto Alves
- Glaucio ValdameriGVGlaucio Valdameri
- Vivian R. MoureVMVivian R. Moure
- Geraldo PichethGPGeraldo Picheth
Open Access
- 11 April 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (4) , 486
Abstract
Diabetes mellitus (DM) complications are a burden to health care systems due to the associated consequences of poor glycemic control and the side effects of insulin therapy. Recently. adjuvant therapies, such as vanadium compounds, have gained attention due to their potential to improve glucose homeostasis in patients with diabetes. In order to determine the anti-diabetic and antioxidant effects of the oxidovanadium(IV) complex (Et3NH)2[{VO(OH}2)(ox)2(µ–ox)] or Vox2), rats with streptozotocin (STZ)-induced diabetes were treated with 30 and 100 mg/kg of Vox2, orally administered for 12 days. Vox2 at 100 mg/kg in association with insulin caused a 3.4 times decrease in blood glucose in STZ rats (424 mg/dL), reaching concentrations similar to those in the normoglycemic animals (126 mg/dL). Compared to insulin alone, the association with Vox2 caused an additional decrease in blood glucose of 39% and 65% at 30 and 100 mg/kg, respectively, and an increased pancreatic GSH levels 2.5 times. Vox2 alone did not cause gastrointestinal discomfort, diarrhea, and hepatic or renal toxicity and was not associated with changes in blood glucose level, lipid profile, or kidney or liver function. Our results highlight the potential of Vox2 in association with insulin in treating diabetes.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (405105/2021-5, 310290/2021-0, 001)
- Fundação Araucária, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) (405105/2021-5, 310290/2021-0, 001)
- Programa Institucional de Internacionalização da CAPES (CAPES—PrInt) (405105/2021-5, 310290/2021-0, 001)
- Universidade Federal do Paraná (UFPR) (405105/2021-5, 310290/2021-0, 001)
This publication has 114 references indexed in Scilit:
- Mini review–vanadium-induced neurotoxicity and possible targetsNeurological Sciences, 2019
- Characterization and Insulin‐Mimetic Potential of Oxidovanadium(IV) Complexes Derived from Monoesters and ‐carboxylates of 2,5‐Dipicolinic AcidEuropean Journal of Inorganic Chemistry, 2006
- A New Family of Insulin‐Mimetic Vanadium Complexes Derived from 5‐CarboalkoxypicolinatesChemistry – A European Journal, 2003
- Synthesis, structure analysis, solution chemistry, and in vitro insulinomimetic activity of novel oxovanadium(IV) complexes with tripodal ligands containing an imidazole group derived from amino acidsJBIC Journal of Biological Inorganic Chemistry, 2003
- Diabetes, oxidative stress, and antioxidants: A reviewJournal of Biochemical and Molecular Toxicology, 2003
- Orally Active and Long-Term Acting Insulin-Mimetic Vanadyl Complex: Bis(Picolinato)oxovanadium(IV)Biochemical and Biophysical Research Communications, 1995
- Toxicology of vanadium compounds in diabetic rats: The action of chelating agents on vanadium accumulationMolecular and Cellular Biochemistry, 1995
- Tissue-specific correction of lipogenic enzyme gene expression in diabetic rats given vanadateDiabetologia, 1994
- Lipid hydroperoxide measurement by oxidation of Fe2+ in the presence of xylenol orange. Comparison with the TBA assay and an iodometric methodLipids, 1991
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981